Patents by Inventor Alison Michelle Griffin

Alison Michelle Griffin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130017608
    Abstract: This invention relates to a novel Pleuromutilin gene cluster and methods of increasing yields of Pleuromutilin produced by Clitopilus and related basidiomycete species.
    Type: Application
    Filed: October 28, 2010
    Publication date: January 17, 2013
    Applicant: Glaxo Wellcome House
    Inventors: Andrew Mark Bailey, Gatherine Collins, Amanda Crawford, Gary Foster, Alison Michelle Griffin, Sreedhar Kilaru, Angela Scrogham, David Spence
  • Patent number: 7622302
    Abstract: New processes for improving the manufacture of clavams e.g. clavulanic acid. Novel DNA sequences and new microorganisms capable of producing increased amounts of clavulanic acid are also disclosed.
    Type: Grant
    Filed: April 13, 2004
    Date of Patent: November 24, 2009
    Assignees: Glaxo Group Limited, The Governors of the University of Alberta
    Inventors: Barry Barton, Alison Michelle Griffin, Susan Jensen, Annie Wong
  • Patent number: 5858759
    Abstract: Processes are provided for the production of a carbamoylase enzyme which has the capability of converting a D-N-carbamoyl (optionally substituted phenyl) glycine by expressing recombinant DNA encoding a carbamoylase in a homologous host. Also provided are specific recombinant DNA vectors producing high levels of expression of the carbamoylase enzyme and/or hydantoinase enzyme in homologous and heterologous hosts and their use in the production of D-.alpha. amino acids.
    Type: Grant
    Filed: March 11, 1997
    Date of Patent: January 12, 1999
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Robert John Neal, Alison Michelle Griffin, Hazel Claire Gorham